UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report: August 1, 2006
(Date of earliest event reported)
GENOMIC HEALTH, INC.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Delaware
|
|
000-51541
|
|
77-0552594 |
|
|
|
|
|
|
(State or Other
Jurisdiction of
Incorporation)
|
|
(Commission File
Number)
|
|
(I.R.S. Employer
Identification Number) |
| |
|
|
301 Penobscot Drive
Redwood City, California
|
|
94063 |
|
|
|
|
(Address of principal
executive
offices)
|
|
(Zip Code) |
(650) 556-9300
(Registrant’s telephone number,
including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
TABLE OF CONTENTS
Item 2.02 Results of Operations and Financial Condition.
On August 1, 2006, Genomic Health, Inc. issued a press release announcing financial results
for its second fiscal quarter ended June 30, 2006. The full text of the press release is furnished
as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| |
|
|
|
|
99.1 Press release issued by Genomic Health, Inc. dated August 1, 2006. |
2